RxDoctor Payments Data

Jenna Stump

Physician Assistant · Kingsley, MINPI 1710119847

Payments from drug & device makers

$2,897in general payments, 2019–2025

Across 126 payments — averaging $22.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$812
  • GSK$528
  • AstraZeneca$412
  • Novo Nordisk$339
  • Axsome Therapeutics, Inc.$164
  • Lilly USA, LLC$133
  • plus $509 from 10 others

What the payments were for

  • Food & beverage$2,897100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,897 in reported general payments places this provider in the 85th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide95$126,873
Trelegy ElliptaFluticasone/Umeclidin/Vilanter79$86,526
OzempicSemaglutide71$83,209
TrulicityDulaglutide39$46,238
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog20$34,516
EliquisApixaban30$30,377
VraylarCariprazine Hcl12$28,895
Breo ElliptaFluticasone/Vilanterol34$22,279
JardianceEmpagliflozin26$21,960
LyricaPregabalin12$15,505
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr15$7,336
LinzessLinaclotide12$6,646
Incruse ElliptaUmeclidinium Bromide12$4,761
Atorvastatin Calcium371$4,715
Saxagliptin Hcl12$4,396

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$133$173,111134 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta$528$120,902140 claims
Novo NordiskOzempic$339$83,20971 claims
AbbVieVraylar, Linzess$812$35,54124 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$21$4,29511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Kingsley

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →